San Francisco, CA, United States of America

Paul D Ponath

USPTO Granted Patents = 35 

 

 

Average Co-Inventor Count = 3.9

ph-index = 11

Forward Citations = 590(Granted Patents)


Location History:

  • Boston, MA (US) (2001 - 2010)
  • San Francisco, CA (US) (2005 - 2021)

Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paul D Ponath

Introduction. Paul D Ponath, located in San Francisco, CA, has made significant strides in the field of biotechnology and immunology with a remarkable portfolio of 35 patents. His innovative work primarily focuses on developing therapies for cancer treatment and enhancing immune responses.

Latest Patents. Among his latest inventions are groundbreaking patents that address critical medical challenges. One patent discusses a combination therapy for lung cancer, which utilizes an anti-fucosyl-GM1 antibody alongside an anti-CD137 antibody. This combination aims to effectively treat patients afflicted with lung cancer. Another patent details methods to induce or enhance immune responses by using agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies. This innovation provides binding molecules that demonstrate high affinity for human GITR on T cells and dendritic cells, with the potential to modulate immune responses in various clinical applications.

Career Highlights. Throughout his career, Paul has worked with prominent companies, including Millennium Pharmaceuticals Limited and Gitr, Inc. His contributions to the field have gained recognition, and his patents play a crucial role in the landscape of cancer immunotherapy.

Collaborations. Paul D Ponath has collaborated with notable colleagues, including Michael Rosenzweig and Jose F Ponte, contributing to the advancement of research and development in immunotherapy. These collaborations have fostered innovation and led to the creation of significant therapeutic strategies.

Conclusion. With a strong emphasis on research and development, Paul D Ponath continues to be an influential figure in the biotechnology sector. His dedication to creating novel therapies and enhancing immune responses makes his work invaluable in the fight against cancer and other diseases. As he pursues further innovations, the impact of his patents will likely resonate throughout the scientific and medical communities for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…